L&K Biopharm CEO Kang Guk-jin holds 2,553,789 shares (11.43% stake)

insider · spotted Aug 3, 2026, 5:40 PM KST

• Kang Guk-jin, representative director (대표이사) and registered executive officer (등기임원), reported ownership of 2,553,789 shares as of filing date 3 August 2026.
• Stake represents 11.43% of outstanding shares, qualifying him as a major shareholder (10% 이상주주).
• Pledged shares total 36,630 units (0.08% of total shares), indicating collateralised debt against a portion of his holding.

Executive share pledging reduces liquidity available to the shareholder and may signal financing needs or leverage; material changes in pledged amounts or ownership concentration affect market price and capital structure mechanics.

AI-generated summaries of public DART filings. May contain errors — always verify against the original (linked). Not investment advice.